Home LiteratureArticle Details
PMID: 21660454 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Association of secondhand smoke exposures with DNA methylation in bladder carcinomas.

Cancer causes & control : CCC ·Vol. 22 ·No. 8 ·2011-08-00 ·Pages 1205-13

Wilhelm-Benartzi CS, Christensen BC, Koestler DC, Houseman EA, Schned AR, Karagas MR, Kelsey KT, Marsit CJ

Abstract

The association between secondhand smoke (SHS) exposure and bladder cancer is inconclusive. Epigenetic alterations in bladder tumors have been linked to primary cigarette smoking and could add to the biological plausibility of an association between SHS exposure and bladder cancer. SHS exposure is associated with DNA methylation in bladder tumors. Using an array-based approach, we profiled DNA methylation from never smoking cases of incident bladder cancer. Analyses examined associations between individual loci's methylation with SHS variables (exposure in adulthood, childhood, occupationally, and total exposure). A canonical pathway analysis was used to find pathways significantly associated with each SHS exposure type. There is a trend toward increased methylation of numerous CpG loci with increasing exposure to adulthood, occupational, and total SHS. Discrete associations between methylation extent of several CpG loci and SHS exposures demonstrated significantly increased methylation of these loci across all types of SHS exposure. CpGs with SHS-related methylation alterations were associated with genes in pathways involved in carcinogenesis, immune modulation, and immune signaling. Exposures to SHS in adulthood, childhood, occupationally, and in total are each significantly associated with changes in DNA methylation of several CpG loci in bladder tumors, adding biological plausibility to SHS as a risk factor for bladder cancer.

MeSH Terms
DNA Methylation Environmental Exposure Female Humans Male Middle Aged Smoke Tobacco Smoke Pollution/adverse effects Urinary Bladder Neoplasms/etiology,genetics
Chemicals
Smoke Tobacco Smoke Pollution
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Wilhelm-Benartzi Charlotte S
Department of Community Health Center for Environmental Health and Technology, Brown University, Providence, RI, USA.
Christensen Brock C
Koestler Devin C
Houseman E Andres
Schned Alan R
Karagas Margaret R
Kelsey Karl T
Marsit Carmen J
References (45)
45 references, click to expand
  1. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
    Nat Rev Cancer. 2006 Feb;6(2):107-16 PMID: 16491070
  2. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers.
    J Anal Toxicol. 2006 Apr;30(3):187-95 PMID: 16803653
  3. MGMT gene silencing and benefit from temozolomide in glioblastoma.
    N Engl J Med. 2005 Mar 10;352(10):997-1003 PMID: 15758010
  4. Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis.
    Int J Mol Med. 2004 Nov;14(5):825-36 PMID: 15492852
  5. Identification of methylated genes associated with aggressive bladder cancer.
    PLoS One. 2010 Aug 23;5(8):e12334 PMID: 20808801
  6. Risk of bladder cancer by source and type of tobacco exposure: a case-control study.
    Int J Cancer. 1989 Oct 15;44(4):622-8 PMID: 2793235
  7. A road map for those who don't know JAK-STAT.
    Science. 2002 May 31;296(5573):1653-5 PMID: 12040185
  8. A case-control study of smoking and bladder cancer risk: emergent patterns over time.
    J Natl Cancer Inst. 2009 Nov 18;101(22):1553-61 PMID: 19917915
  9. Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.
    Blood. 2010 Mar 25;115(12):2412-9 PMID: 20061560
  10. Dose-response relationship in tobacco-related cancers of bladder and lung: a biochemical interpretation.
    Int J Cancer. 2004 Jan 1;108(1):2-7 PMID: 14618608
  11. The fundamental role of epigenetic events in cancer.
    Nat Rev Genet. 2002 Jun;3(6):415-28 PMID: 12042769
  12. Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.
    Cancer Res. 2005 Aug 15;65(16):7081-5 PMID: 16103055
  13. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Life Sci. 2010 Jul 17;87(3-4):83-91 PMID: 20470789
  14. Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.
    PLoS One. 2009 Dec 21;4(12):e8357 PMID: 20027224
  15. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
    J Cell Physiol. 2010 Oct;225(1):168-73 PMID: 20458733
  16. Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.
    Exp Cell Res. 2010 May 15;316(9):1479-88 PMID: 20338164
  17. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands).
    Cancer Causes Control. 2002 Feb;13(1):83-90 PMID: 11899922
  18. Aromatic amines and cancer.
    Cancer Causes Control. 1997 May;8(3):346-55 PMID: 9498898
  19. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.
    Cancer Causes Control. 2004 Jun;15(5):465-72 PMID: 15286466
  20. Erythropoietin in cancer: an update.
    Curr Mol Med. 2008 Sep;8(6):481-91 PMID: 18781955
  21. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.
    Cancer Res. 2005 Nov 15;65(22):10170-3 PMID: 16288001
  22. Focus on bladder cancer.
    Cancer Cell. 2004 Aug;6(2):111-6 PMID: 15324694
  23. ERK5 and the regulation of endothelial cell function.
    Biochem Soc Trans. 2009 Dec;37(Pt 6):1254-9 PMID: 19909257
  24. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen.
    Mol Vis. 2006 Aug 10;12:885-91 PMID: 16917481
  25. Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.
    Cell. 1986 Oct 10;47(1):3-10 PMID: 3489530
  26. Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer.
    Carcinogenesis. 2007 Aug;28(8):1745-51 PMID: 17522068
  27. Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
    Nat Clin Pract Urol. 2005 Oct;2(10):502-10 PMID: 16474624
  28. High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer.
    Nucleic Acids Res. 2006 Jan 23;34(2):555-63 PMID: 16432260
  29. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake.
    PLoS Genet. 2010 Jul 29;6(7):e1001043 PMID: 20686660
  30. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma.
    Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):108-14 PMID: 17220338
  31. Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology.
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2003 May;21(1):29-43 PMID: 12826031
  32. Passive smoking in adulthood and cancer risk.
    Am J Epidemiol. 1985 Jan;121(1):37-48 PMID: 3964991
  33. Bladder cancer.
    Lancet. 2009 Jul 18;374(9685):239-49 PMID: 19520422
  34. Urinary excretion of mutagens in smokers of cigarettes with various tar and nicotine yields, black tobacco, and cigars.
    Cancer Lett. 1987 Jan;34(1):103-12 PMID: 3802064
  35. The global burden of urinary bladder cancer.
    Scand J Urol Nephrol Suppl. 2008 Sep;(218):12-20 PMID: 19054893
  36. High-throughput DNA methylation profiling using universal bead arrays.
    Genome Res. 2006 Mar;16(3):383-93 PMID: 16449502
  37. Nonsmoking-related arylamine exposure and bladder cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):503-7 PMID: 12814994
  38. Prevention of bladder cancer.
    N Engl J Med. 1999 May 6;340(18):1424-6 PMID: 10228196
  39. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
    J Natl Cancer Inst. 2001 Mar 7;93(5):378-81 PMID: 11238699
  40. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
    Carcinogenesis. 2006 Jan;27(1):112-6 PMID: 15987713
  41. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population.
    Environ Health Perspect. 1998 Aug;106 Suppl 4:1047-50 PMID: 9703491
  42. Human cancer from environmental pollutants: the epidemiological evidence.
    Mutat Res. 2006 Sep 28;608(2):157-62 PMID: 16843042
  43. T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing.
    Trends Mol Med. 2010 Feb;16(2):77-87 PMID: 20122868
  44. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
    Cancer Res. 2007 Aug 1;67(15):7095-105 PMID: 17671176
  45. A mechanism for the initiation of allergen-induced T helper type 2 responses.
    Nat Immunol. 2008 Mar;9(3):310-8 PMID: 18300366
Article Info
Journal
Cancer causes & control : CCC
Abbr.
Cancer Causes Control
ISSN
1573-7225
Published
2011-08-00
Epub
2011-00-10
Pages
1205-13
Language
English
Region
Netherlands
NLM ID
9100846
PMCID
PMC3140591
Subset
IM
Grants
NCI NIH HHS · R01 CA057494 · United States
NIEHS NIH HHS · P42 ES007373 · United States
NCI NIH HHS · R01 CA121147 · United States
NIEHS NIH HHS · P42ES007373 · United States
NCI NIH HHS · P30 CA023108 · United States
NCI NIH HHS · R01CA121147 · United States
NIEHS NIH HHS · P42 ES007373-18 · United States
NCI NIH HHS · R01 CA057494-06 · United States
NCI NIH HHS · R01CA057494 · United States
NCI NIH HHS · R01 CA121147-04 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com